Frazier Life Sciences raises over $1.3bn for 12th venture fund
FLS XII will primarily invest in early-stage private biopharmaceutical companies.
FLS XII will primarily invest in early-stage private biopharmaceutical companies.
Copyright PEI Media
Not for publication, email or dissemination
